LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma
Clinical trial NCT02138929 · COMPLETED
Trial details
- NCT number
- NCT02138929
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-10
- Primary completion
- 2020-06-08
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.